Hostname: page-component-857557d7f7-gtc7z Total loading time: 0.001 Render date: 2025-11-28T12:01:28.062Z Has data issue: false hasContentIssue false
  • English
  • Français

Adrenoleukodystrophy

Published online by Cambridge University Press:  18 September 2015

Brian P. O’Neill  and
Hugo W. Moser
Brian P. O’Neill*
Affiliation:
the Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, MN (Dr. O’Neill) and the John F. Kennedy Institute and Department of Neurology, The Johns Hopkins Medical Institutions, Baltimore, MD (Dr. Moser)
Hugo W. Moser
Affiliation:
the Department of Neurology, Mayo Clinic and Mayo Foundation, Rochester, MN (Dr. O’Neill) and the John F. Kennedy Institute and Department of Neurology, The Johns Hopkins Medical Institutions, Baltimore, MD (Dr. Moser)
*
Department of Neurology, Mayo Clinic and Foundation, Rochester, MN 55901
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Adrenoleukodystrophy (ALD) is an X-linked degenerative disease characterized by progressive demyelination and adrenal insufficiency. Several phenotypes are described. In post-mortem tissues there is an accumulation of saturated or mono-unsaturated very long chain fattyacids (VLCFA) in the cholesterol ester fraction of adrenal cortex and cerebral white matter. The accumulated fatty acids are unbranched with carbon chain length between 23 and 32 with most containing 25 or 26 carbons. Determination of VLCFA in readily accessible tissues such as skin fibroblasts and plasma allows for reliable detection of patients and carriers.

Information

Type
Subject Review
Information
Canadian Journal of Neurological Sciences , Volume 9 , Issue 4 , November 1982 , pp. 449 - 452
Copyright
Copyright © Canadian Neurological Sciences Federation 1982

References

Antony, G.J., Landau, B.R., (1968). Relative contributions of α-, β-, and ι – oxidative pathways to in vitro fatty acid oxidation in rat liver. J Lipid Res., 9: 267–269.CrossRefGoogle Scholar
Askanas, v., Mclaughlin, J., Engel, W.K., Adornato, B.T., (1979). Abnormalities in cultured muscle and peripheral nerve of a patient with adrenomyeloneuropathy. N Engl J Med, 301: 588–590.CrossRefGoogle ScholarPubMed
Blaw, M.E., (1970). Melanodermic type leukodystrophy (adrenoleukodystrophy). In: Vinken, P.J., Bruyn, G.W., eds. Handbook of Clinical Neurology. Leucodystrophies and Poliodystrophies. Amsterdam: North Holland Publishing Company, 10: 128–133.Google Scholar
Davis, L.E., Snyder, R.D., Orth, D.N., Nicholson, W.E., Kornfeld, M., Seelinger, D.F., (1979). Adrenoleukodystrophy and adrenomyeloneuropathy associated with partial adrenal insufficiency in three generations of a kindred. Am J Med, 66: 342–347.CrossRefGoogle ScholarPubMed
Dyck, P.J., Yao, J.K., Knickerbocker, D.E., Holman, R.T., Gomez, M.R., Hayles, A.B., Lambert, E.H., (1981). Multi-system neuronal degeneration, hepatosplenomegaly and adrenal cortical deficiency associated with reduced tissue arachidonic acid. Neurology (Ny), 31: 925–934.CrossRefGoogle Scholar
Furuse, M., Obayashi, T., Tsuji, S., Miyatake, T., (1978). Adrenoleukodystrophy: a correlative analysis of computed tomography and radionuclide studies. Radiology, 126: 707–710.CrossRefGoogle ScholarPubMed
Ghatak, N.R., Nochlin, D., Peris, M., Myer, E.C., (1981). Morphology and distribution of cytoplasmic inclusions in adrenoleukodystrophy. J Neurol Sci, 50: 391–398.CrossRefGoogle ScholarPubMed
Griffin, J.W., Goren, E., Schaumburg, H., Engel, W.K., Loriaux, L., (1977). Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects. Neurology (Minneap), 27: 1107–1113.CrossRefGoogle ScholarPubMed
Igarashi, M., Schaumburg, H.H., Powers, J., Kishimoto, Y., Kolodny, E., Suzuki, K., (1976). Fatty acid abnormality in adrenoleukodystrophy. J Neurochem, 26: 851–860.CrossRefGoogle ScholarPubMed
Kawamura, N., Moser, A.B.. Moser, H.W., Ogino, T., Suzuki, K., Schaumburg, H., Milunsky, A., Murphy, J., Kishimoto, Y., (1978). High concentration of hexacosanoate in cultured skin fibroblast lipids from adrenoleukodystrophy patients. Biochem Biophys Res Comm, 82: 114–120.CrossRefGoogle ScholarPubMed
Kishimoto, Y., Moser, H.W., Kawamura, N., Platt, M., Pallante, S.L., Fenselau, C. (1980). Adrenoleukodystrophy: evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin. Biochem Biophys Res Comm, 96: 69–76.CrossRefGoogle ScholarPubMed
Lane, B., Carroll, B.A., Pedley, T.A.. (1978). Computerized cranial tomography in cerebral diseases of white matter. Neurology (Minneap), 28: 534–544.CrossRefGoogle ScholarPubMed
Lyon, M.F., (1961). Gene action in the X-chromosome of the mouse Mus musculus L.). Nature, 190: 372–373.CrossRefGoogle ScholarPubMed
Manz, H.J., Schuelein, M., Mccullough, D.C., Kishimoto, Y., Eiben, R.M., (1980). New phenotypic variant of adrenoleukodystrophy: pathologic, ultrastructural, and biochemical study in two brothers. J Neurol Sci, 45: 245–260.CrossRefGoogle ScholarPubMed
Menkes, J.H., Corbo, L.M., (1977). Adrenoleukodystrophy: accumulation of cholesterol esters with very long chain fatty acids. Neurology (Minneap), 27: 928–932.CrossRefGoogle ScholarPubMed
Migeon, B.R., Moser, H.W., Moser, A.B., Axelman, J., Sillence, D., Norum, R.A., (1981). Adrenoleukodystrophy: evidence for X linkage, inactivation, and in vitro selection favoring mutant allele in heterozygous cells. Proc Nat Acad Sci USA, 78: 5066–5070.CrossRefGoogle ScholarPubMed
Moser, H.W., Moser, A.B., Kawamura, N., Murphy, J., Suzuki, K., Schaumburg, H., Kishimoto, Y., (1980a). Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts. Ann Neurol, 7: 542–549.CrossRefGoogle ScholarPubMed
Moser, H.W., Moser, A.B., Kawamura, N., Migeon, B., O’Neill, B., Fenselau, C., Kishimoto, Y., (1980b). Adrenoleukodystrophy: studies of the phenotype, genetics and biochemistry. Johns Hopkins Med J, 147: 217–224.Google ScholarPubMed
Moser, H.W., Moser, A.B., Frayer, K.K., Chen, W., Schulman, J.D., O’Neill, B.P., Kishimoto, Y., (1981). Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology (Ny), 31: 1241–1249.CrossRefGoogle ScholarPubMed
O’Neill, B.P., Forbes, G.S., (1981). Computerized tomography and adrenoleukomy-eloneuropathy: differential appearance in disease subtypes. Arch Neurol, 38: 293–298.CrossRefGoogle Scholar
O’Neill, B.P., Marmion, L.C., Feringa, E.R., (1981). The adrenoleukodystrophy complex: expression in four generations. Neurology (Ny), 31: 151–156.CrossRefGoogle Scholar
O’Neill, B.P., Moser, H.W., Marmion, L.C., (1982a). Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts and correlation with disease expression in three generations of a kindred. Neurology (Ny), 32: 540–543.CrossRefGoogle ScholarPubMed
O’Neill, B.P., Moser, H.W., Saxena, K.M., (1982b). Familial X-linked Addison disease as an expression of adrenoleukodystrophy (ALD): elevated C26 fatty acid in cultured skin fibroblasts. Neurology (Ny), 32: 543–547.CrossRefGoogle ScholarPubMed
O’Neill, B.P., Moser, H.W., Saxena, K.M., Marmion, L.C., (1982c). Adrenoleukodystrophy (ALD). Neurological disease in carriers and correlation with very long chain fatty acid (VLCFA) concentrations in plasma and cultured skin fibroblasts. Neurology (Ny), 32(2): A216–217.Google Scholar
Osmundsen, H., Neat, C.E., Norum, K.R., (1979). Peroxisomal oxidation of long chain fatty acids. FEBS Lett, 99: 292–296.CrossRefGoogle ScholarPubMed
Pilz, P., Schiener, P., (1973), Kombination von Morbus Addison und Morbus Schilder bei einer 43 jährigen Frau. Acta Neuropathol (Berl), 26: 357–360.CrossRefGoogle Scholar
Powers, J.M., Schaumburg, H.H., Johnson, A.B., Raine, C.S., (1980). A correlative study of the adrenal cortex in adrenoleukodystrophy – evidence for a fatal intoxication with very long chain saturated fatty acids. Invest Cell Pathol, 3: 353–376.Google ScholarPubMed
Ramsey, R.B., Banik, N.L., Davison, A.N., (1979). Adrenoleukodystrophy brain cholesteryl esters and other neutral lipids. J Neurol Sci, 40: 189–196.CrossRefGoogle ScholarPubMed
Rosenberg, R.N., (1981). Biochemical genetics of neurologic disease. N Engl J Med, 305: 1181–1193.CrossRefGoogle ScholarPubMed
Schaumburg, H.H., Richardson, E.P., Johnson, P.C., Cohen, R.B., Powers, J.M., Raine, C.S., (1972). Schilder’s disease: sex-linked recessive transmission with specific adrenal changes. Arch Neurol, 27: 458–460.CrossRefGoogle ScholarPubMed
Schaumburg, H.H., Powers, J.M., Raine, C.S., Suzuki, K., Richardson, E.P., (1975). Adrenoleukodystrophy: a clinical and pathological study of 17 cases. Arch Neurol, 32: 577–591.CrossRefGoogle ScholarPubMed
Schaumburg, H.H., Powers, J.M., Raine, C.S., Johnson, A.B., Kolodny, E.H., Kishimoto, Y., Igarashi, M., Suzuki, K., (1976). Adrenoleukodystrophy: a clinical, pathological and biochemical study. Adv Exp med Biol, 68: 379–387.CrossRefGoogle ScholarPubMed
Schaumburg, H.H., Powers, J.M., Raine, C.S., Spencer, P.S., Griffin, J.W., Prineas, J.W., Boehme, D.M., (1977). Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic and biochemical aspects. Neurology (Minneap), 27: 1114–1119.CrossRefGoogle ScholarPubMed
Siemerling, E., Creutzfeldt, H.G., (1923). Bronzekrankheit und sklerosierende encephalomyelitis (diffuse sklerose). Arch Psychiat Nervenkrank, 68: 217–244.CrossRefGoogle Scholar
Steinberg, D., (1978). Phytanic acid storage disease: Refsum’s syndrome. In: Stanbury, JB., Wyngaarden, JB., Frederickson, DS., eds. The Metabolic Basis of Inherited Disease. 4th edit. New York: McGraw-Hill; 688–706.Google Scholar
Ulrich, J., Herschkowitz, N., Heitz, P., Sigrist, T., Baerlocher, P., (1978). Adrenoleukodystrophy: preliminary report of a connatal case: light- and electron microscopical, immunohistochemical and biochemical findings. Acta Neuropathol, 43: 77–83.CrossRefGoogle ScholarPubMed
Weiss, G.M., Nelson, R.L., O’Neill, B.P., Carney, J.A., Edis, A.J., (1980). Use of adrenal biopsy in diagnosing adrenoleukomyeloneuropathy. Arch Neurol, 37: 634–636.CrossRefGoogle ScholarPubMed